Company news
Fresenius SE & Co. KGaA news in 2025
Fresenius SE & Co. KGaA's news releases, calls and decks from 2025, newest first.
Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature
December 18, 2025
mAbxience and HP drive the use of artificial intelligence in biomanufacturing and biosimilar development
December 4, 2025
Fresenius Kabi’s Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers
November 12, 2025
FDA Grants Interchangeable Designation to Fresenius Kabi’s Biosimilars Conexxence® and Bomyntra® (denosumab-bnht)
October 29, 2025
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient®
September 25, 2025
Fresenius Leads New EASYGEN Consortium Aimed at Decentralizing CAR-T Cell Therapy and Improving Hospital Workflows
August 26, 2025
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
July 17, 2025
Calls in 2025
- Fresenius SE & Co. KGaA (Xetra:FRE) Q3 2025 Earnings Call
Nov 6, 2025
Transcript - Fresenius SE & Co. KGaA (Xetra:FRE) Q2 2025 Earnings Call
Aug 6, 2025
Transcript - Fresenius SE & Co. KGaA (Xetra:FRE) Q1 2025 Earnings Call
May 7, 2025
Transcript - Fresenius SE & Co. KGaA (Xetra:FRE) Q4 2024 Earnings Call
Feb 26, 2025
Transcript
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 50 slides · Nov 6, 2025
- Q2 2025 Earnings Presentation
Earnings · 52 slides · Aug 6, 2025
- Q1 2025 Earnings Presentation
Earnings · 40 slides · May 7, 2025
- Q4 2024 Earnings Presentation
Earnings · 49 slides · Feb 26, 2025